Products Categories
CAS No.: | 820-75-7 |
---|---|
Name: | N-diazoacetylglycine hydrazide |
Molecular Structure: | |
Formula: | C4H7 N5 O2 |
Molecular Weight: | 157.132 |
Synonyms: | Glycine,N-(diazoacetyl)-, hydrazide (7CI,8CI,9CI); Diazoacetylglycine hydrazide;N-(Diazoacetyl)glycine hydrazide |
Density: | 1.5005 (rough estimate) |
Boiling Point: | 281.77°C (rough estimate) |
Safety: | Poison by intravenous route. Moderately toxic by ingestion, intraperitoneal, and subcutaneous routes. Questionable carcinogen with experimental carcinogenic and neoplastigenic data. Mutation data reported. When heated to decomposition it emits toxic fumes including NOx. |
PSA: | 121.61000 |
LogP: | -1.04374 |
What can I do for you?
Get Best Price
Product Name: N-Diazoacetylglycine hydrazide (CAS NO.820-75-7)
Molecular Formula: C4H7N5O2
Molecular Weight: 157.16g/mol
Mol File: 820-75-7.mol
XLogP3-AA: 0.2
H-Bond Donor: 3
H-Bond Acceptor: 5
Structure Descriptors of N-Diazoacetylglycine hydrazide (CAS NO.820-75-7):
IUPAC Name: (Z)-2-diazonio-1-[(2-hydrazinyl-2-oxoethyl)amino]ethenolate
Canonical SMILES: C(C(=O)NN)NC(=C[N+]#N)[O-]
Isomeric SMILES: C(C(=O)NN)N/C(=C/[N+]#N)/[O-]
InChI: InChI=1S/C4H6N5O2/c5-8-2-3(10)7-1-4(11)9-6/h2,6-7,10H,1H2/q-1/p+1/b3-2-
InChIKey: WLRJOPROJKADBZ-IHWYPQMZSA-O
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
dog | LDLo | intravenous | 39mg/kg (39mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) LUNGS, THORAX, OR RESPIRATION: DYSPNEA GASTROINTESTINAL: NAUSEA OR VOMITING | Cancer Chemotherapy Reports, Part 1. Vol. 53, Pg. 13, 1969. |
mouse | LD50 | intraperitoneal | 2575mg/kg (2575mg/kg) | GASTROINTESTINAL: OTHER CHANGES LIVER: OTHER CHANGES KIDNEY, URETER, AND BLADDER: OTHER CHANGES | Cancer Chemotherapy Reports, Part 1. Vol. 53, Pg. 13, 1969. |
mouse | LD50 | oral | 3852mg/kg (3852mg/kg) | GASTROINTESTINAL: OTHER CHANGES | Cancer Chemotherapy Reports, Part 1. Vol. 53, Pg. 13, 1969. |
mouse | LD50 | subcutaneous | 2985mg/kg (2985mg/kg) | LUNGS, THORAX, OR RESPIRATION: EMPHYSEMA CARDIAC: OTHER CHANGES GASTROINTESTINAL: OTHER CHANGES | Cancer Chemotherapy Reports, Part 1. Vol. 53, Pg. 13, 1969. |
rabbit | LDLo | intravenous | 833mg/kg (833mg/kg) | BEHAVIORAL: MUSCLE WEAKNESS LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION LUNGS, THORAX, OR RESPIRATION: DYSPNEA | Cancer Chemotherapy Reports, Part 1. Vol. 53, Pg. 13, 1969. |
rat | LD50 | intraperitoneal | 1335mg/kg (1335mg/kg) | LUNGS, THORAX, OR RESPIRATION: EMPHYSEMA BEHAVIORAL: MUSCLE CONTRACTION OR SPASTICITY) GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA" | Cancer Chemotherapy Reports, Part 1. Vol. 53, Pg. 13, 1969. |
rat | LD50 | intravenous | 1595mg/kg (1595mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) LUNGS, THORAX, OR RESPIRATION: CYANOSIS LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES | Cancer Chemotherapy Reports, Part 1. Vol. 53, Pg. 13, 1969. |
EPA Genetic Toxicology Program.
Poison by intravenous route. Moderately toxic by ingestion, intraperitoneal, and subcutaneous routes. Questionable carcinogen with experimental carcinogenic and neoplastigenic data. Mutation data reported. When heated to decomposition it emits toxic fumes including NOx.
N-Diazoacetylglycine hydrazide ,its CAS NO. is 820-75-7,the synonyms is AI3-52380 ; CCRIS 929 ; DGI ; Diazoacetylglycine hydrazide ; N-(Diazoacetyl)glycine hydrazine ; N-Diazoacetilglicina-idrazide ; N-Diazoacetyl glycyclhydrazide ; NSC 58404 ; Glycine, N-(diazoacetyl)-, hydrazide .